Danielle Marie Rischling , APRN
Family Medicine β’ Omaha, NE
302 N 168th Cir Ste 208
Omaha, NE 681184089
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Danielle Rischling is listed in NPPES under Family Medicine.
-
NPI assigned on September 9, 2020; this date does not establish years in practice.
-
Published CMS data list 694 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium β 114 prescription fills, including refills.
- Losartan Potassium β 57 prescription fills, including refills.
- Pantoprazole Sodium β 43 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 65% of clinicians listed under Family Medicine in Omaha, NE (2024, 279 clinicians with data). Median for this group: 1,590. Middle half: 289 to 4,872.
Fewer Part D prescriptions than 70% of clinicians listed under Family Medicine in Nebraska (2024, 856 clinicians with data). Median for this group: 3,013. Middle half: 436 to 6,425.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 12 in 2020 to 694 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020β2024.
Practice Location & Contact Primary Location
302 N 168th Cir Ste 208
Omaha, NE 681184089
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2020
What Public CMS Data Show
Family Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,054 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$17,231 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $761.87 across 16 records.
By nature of payment
- Food and Beverage: $761.87 across 16 records.
Reporting-company totals (3 largest of 5)
- ABBVIE INC.: $513.02 across 10 records.
- REVANCE THERAPEUTICS, INC.: $144.70 across 1 record.
- Eli Lilly and Company: $62.42 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
6 years (graduated 2020)
CMS Doctors and Clinicians data list 2020 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2020
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Danielle Rischling has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Danielle Rischling as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Omaha and Nebraska
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Family Medicine in Omaha, NE (2024, 279 clinicians with data). Median for this group: 1,590. Middle half: 289 to 4,872.
Fewer Part D prescriptions than 70% of clinicians listed under Family Medicine in Nebraska (2024, 856 clinicians with data). Median for this group: 3,013. Middle half: 436 to 6,425.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under Family Medicine in Omaha, NE (2024, 279 clinicians with data). Median for this group: $107,863. Middle half: $15,434 to $354,534.
A lower Part D drug cost than 75% of clinicians listed under Family Medicine in Nebraska (2024, 856 clinicians with data). Median for this group: $200,595. Middle half: $24,721 to $436,245.
461 active clinicians are listed under Family Medicine with a practice address in Omaha, NE (1,288 in Nebraska).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Omaha
8.7% of these 461 clinicians have the CMS telehealth indicator.
54.2% of these 461 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 12 in 2020 to 694 in 2024.
- 2020: 12
- 2021: 272
- 2022: 527
- 2023: 759
- 2024: 694
-
30-day fills
30-day fills went from 16 in 2020 to 1,054 in 2024.
- 2020: 16
- 2021: 381
- 2022: 773
- 2023: 1,127
- 2024: 1,054
-
Part D drug cost
Part D drug cost went from $171 in 2020 to $17,231 in 2024.
- 2020: $171
- 2021: $22,645
- 2022: $7,334
- 2023: $28,525
- 2024: $17,231
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $539.56 in 2021 to $761.87 in 2025.
- 2021: $539.56
- 2022: $282.02
- 2023: $302.82
- 2024: $611.13
- 2025: $761.87
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 16 records totaling $761.87.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $144.70 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $113.93 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $97.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $75.34 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
β | General | $55.04 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $45.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $33.27 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $31.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $30.94 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $26.83 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $21.10 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
ZENPEP | General | $20.63 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $20.48 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $17.03 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $14.39 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
ZEPBOUND | General | $14.27 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 114 | 5,310 | $528.35 | 20 |
| Losartan Potassium | Losartan Potassium | 57 | 2,010 | $207.25 | β |
| Pantoprazole Sodium | Pantoprazole Sodium | 43 | 1,590 | $211.51 | β |
| Lisinopril | Lisinopril | 35 | 2,370 | $371.15 | β |
| Amlodipine Besylate | Amlodipine Besylate | 34 | 1,620 | $111.64 | β |
| Hydrochlorothiazide | Hydrochlorothiazide | 29 | 1,530 | $45.97 | β |
| Allopurinol | Allopurinol | 25 | 1,830 | $370.85 | β |
| Atorvastatin Calcium | Atorvastatin Calcium | 25 | 2,190 | $175.66 | β |
| Fluticasone Propionate | Fluticasone Propionate | 22 | 730 | $231.49 | β |
| Duloxetine Hcl | Duloxetine Hcl | 22 | 660 | $291.81 | β |
| Trintellix | Vortioxetine Hydrobromide | 22 | 720 | $11,124.56 | β |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | 630 | $290.37 | β |
| Estradiol | Estradiol | 20 | 1,123 | $284.96 | β |
| Omeprazole | Omeprazole | 17 | 750 | $106.09 | β |
| Clonazepam | Clonazepam | 16 | 480 | $77.81 | β |
| Tamsulosin Hcl | Tamsulosin Hcl | 16 | 675 | $96.43 | β |
| Verapamil Sr | Verapamil Hcl | 16 | 660 | $326.19 | β |
| Metoprolol Succinate | Metoprolol Succinate | 15 | 810 | $380.13 | β |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | 1,200 | $70.74 | β |
| Montelukast Sodium | Montelukast Sodium | 14 | 600 | $102.42 | β |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | 364 | $99.45 | β |
| Azithromycin | Azithromycin | 12 | 56 | $30.41 | β |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | 360 | $77.88 | β |
| Bupropion Xl | Bupropion Hcl | 12 | 381 | $260.75 | β |
| Dilt-Xr | Diltiazem Hcl | 12 | 360 | $255.60 | β |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-06-19NUCC Taxonomy Code: 207Q00000X
Family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20221021002121
NE
5395111934
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 302 N 168TH CIR STE 208, OMAHA, NE 681184089 (Tel: 4029161897)
Registered at 302 N 168TH CIR STE 208, OMAHA, NE 681184089 (Tel: 4029161897)
NPI status registered as active in NPPES database
Registered at 2302 8TH AVE STE 4, PLATTSMOUTH, NE 680482365 (Tel: 4022984347)
Registered at 2302 8TH AVE STE 4, PLATTSMOUTH, NE 680482365 (Tel: 4022984347)
Recorded as DANIELLE RISCHLING, APRN
Family Medicine (license number reported to NPPES: NE F09200335)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Family Medicine Providers in Omaha
- Dr. Elizabeth Gibson, MD
- Dr. Naureen Rafiq, MBBS
- Dr. Bodo Treu, MD
- Dr. Erin Dahlke, DO
- Dr. Keithstone Kim, MD
- Dr. Stephen Tetrault, DO
Mailing Address
302 N 168th Cir Ste 208
Omaha, NE 681184089
Phone: 4029161897